After the explosive success of COVID-19 mRNA vaccines, BioNTech is addressing his beware of cancer. Theirs new cancer treatment, which uses vaccine-like technology, has shown great promise in mice and is now in human experimentation to see if they can bring the same success. Their findings were published in the journal Science Translational Medicine.